ROBERT W.A. SELLERS - 03 May 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
SVP, Corporate Controller
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
03 May 2022
Transactions value $
-$12,288
Form type
4
Filing time
05 May 2022, 17:51:36 UTC
Previous filing
19 May 2021
Next filing
10 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Award $0 +1.18K +10.85% $0.00 12.1K 03 May 2022 Direct F1
transaction EW Common Stock Tax liability -$12.3K -116 -0.96% $105.93 11.9K 04 May 2022 Direct
holding EW Common Stock 20.4K 03 May 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Award $0 +3.48K $0.00 3.48K 03 May 2022 Common Stock 3.48K $105.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units were granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
F2 These options were granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.